Because LAT1 and ASCT2 function cooperatively to regulate leucine transport and activate the mTOR pathway, these covalent inhibitors can be potentially efficacious drugs in suppressing tumor growth by exerting a dual inhibition. The gene discussed is SLC1A5; the disease is neoplasm.